Skip to content

Author

Shinichiro Yoshioka

We have 1 of 51 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

TL1A-DR3 Signaling in Inflammatory Bowel Disease: From Pathogenesis to Therapeutic Targeting.

Current evidence highlights TL1A blockade as a promising dual-pathway therapeutic approach targeting inflammation and fibrotic remodeling, with ongoing studies expected to define its long-term impact on disease modification.

Kozo Tsuruta, Shinichiro Yoshioka, Hidetoshi Takedatsu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.